1. Home
  2. Court Cases

Category: Discovery

California State Court Applies Discovery Stay in Securities Act Claim

Posted by Susan E. Engel, Matthew Rawlinson, and Peter Trombly, Latham & Watkins LLP, on Wednesday, August 31, 2022 Editor's Note: Susan E. Engel and Matthew Rawlinson are partners and Peter Trombly is an associate at

Kester Capital banks on multibillion-dollar drug discovery software market with Optibruim buyout

Drug discovery software provider Optibrium has been bought by Kester Capital in the firm's third deal since closing its £90m sophomore fund.

GGV Capital could collect up to $2.5bn across latest trio of fundraising vehicles

Sino-US private equity investor GGV Capital could collect up to $2.5bn across its trio of new fundraises, new SEC documents submitted by the firm show.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.